Shukra Pharmaceuticals Share Price Live
Live Shukra Pharmaceuticals Share Price Chart
Shukra Pharmaceuticals Performance
Days Range
| Previous Close | ₹38.74 |
|---|---|
| Open | ₹39.54 |
| Volume | 6,70,835 |
| Day's Range | ₹37.01 - ₹38.74 |
|---|---|
| 52W Range | ₹5.86 - ₹44.31 |
| Market Cap | ₹1,696.34 Cr |
Shukra Pharmaceuticals Fundamentals
| ROCE(TTM) | 20.39 |
|---|---|
| P/E Ratio (TTM) | 143.48 |
| P/B Ratio | 25.78 |
| Industry P/E | 40.38 |
| Debt to Equity | 0.06 |
| ROE | 18.17 |
| EPS (TTM) | 0.27 |
| Dividend Yield | 0.03 |
| Book Value | 1.50 |
| Face Value | 1 |
| ROCE(TTM) | 20.39 |
|---|---|
| P/E Ratio (TTM) | 143.48 |
| P/B Ratio | 25.78 |
| Industry P/E | 40.38 |
| Debt to Equity | 0.06 |
| ROE | 18.17 |
|---|---|
| EPS (TTM) | 0.27 |
| Dividend Yield | 0.03 |
| Book Value | 1.50 |
| Face Value | 1 |
Shukra Pharmaceuticals Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 10.58 | 13.27 | 5.39 | 5.88 |
| Expenses | 7.34 | 6.89 | 4.86 | 7.11 |
| Profit before tax | 4.09 | 7.57 | 1.37 | 0.20 |
| Operating Profit | 3.16 | 5.39 | 1.03 | 2.38 |
| Net Profit | 3.16 | 5.39 | 1.03 | 2.38 |
| ESP in Rs | 0.72 | 0.12 | 0.02 | 0.05 |
Shukra Pharmaceuticals Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 50.96% | 50.96% | 50.96% | 50.96% | 50.96% |
| Flls | 0% | 0% | 0% | 0% | 0% |
| Dlls | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| Public | 48.93% | 48.93% | 48.93% | 48.93% | 48.93% |
About Shukra Pharmaceuticals
Relish Pharmaceuticals Ltd is a public limited company with a global perspective, manufacturing, exporting and marketing in both domestic and international markets. The company was incorporated on March 4, 1993 as a private limited company with the name Relish Pharmaceuticals Pvt Ltd. In August 31, 1993, the company was converted into a public limited company and the name was changed to Relish Pharmaceuticals Ltd.
The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.
The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.
The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.
The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.
Parent Organisation
Indian Private
Managing Director
Dakshesh Shah
Founded
1993
NSE Symbol
Top Mutual Funds Invested in Shukra Pharmaceuticals Share
Top Mutual Funds Invested in Shukra Pharmaceuticals Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,809.6 4.70 (0.26%) | ₹4,33,043.97 | 1,548.0 - 1,910.0![]() |
| Divis Laboratories Ltd | 6,487.5 -22.50 (-0.35%) | ₹1,72,877.12 | 4,955.0 - 7,071.5![]() |
| Torrent Pharmaceuticals Ltd | 3,722.1 -33.70 (-0.90%) | ₹1,27,036.56 | 2,886.45 - 3,882.2![]() |
| Cipla Ltd | 1,525.8 2.00 (0.13%) | ₹1,23,059.91 | 1,335.0 - 1,673.0![]() |
| Dr Reddys Laboratories Ltd | 1,248.9 0.90 (0.07%) | ₹1,04,189.94 | 1,020.0 - 1,405.9![]() |
| Zydus Lifesciences Ltd | 936.9 -3.65 (-0.39%) | ₹94,631.28 | 795.0 - 1,059.05![]() |
Popular stocks
Shukra Pharmaceuticals Ltd FAQs
What is the share price of Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) shares?
Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) share price as of November 26, 2025, on NSE is Rs 38.74 (NSE) and Rs 38.74 (BSE) on BSE.
Can I buy Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) from Angel One?
Yes, You can buy Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
How do I buy Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) from Angel One?
Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) shares.
1. Direct investment: You can buy Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Shukra Pharmaceuticals Ltd (Shukra Pharmaceuticals Ltd) shares.




